Coronavirus disease 2019, a popup differential to the postoperative inflammatory state and its impact on outcomes after cardiac surgery – A single-center experience

IF 0.2 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of the Practice of Cardiovascular Sciences Pub Date : 2023-01-01 DOI:10.4103/jpcs.jpcs_47_22
K. Ram Kiran, V. Trivedi, Rajesh P. Venuthurupalli, Deepika Gehlot, Sunil Ninama
{"title":"Coronavirus disease 2019, a popup differential to the postoperative inflammatory state and its impact on outcomes after cardiac surgery – A single-center experience","authors":"K. Ram Kiran, V. Trivedi, Rajesh P. Venuthurupalli, Deepika Gehlot, Sunil Ninama","doi":"10.4103/jpcs.jpcs_47_22","DOIUrl":null,"url":null,"abstract":"Introduction: Coronavirus disease 2019 (COVID-19) affected care among surgical patients. Considering the underlying comorbidities, physical status, and intricate perioperative course, the cardiac surgery patient represents a vulnerable cohort. This study describes baseline characteristics, laboratory findings, diagnosis, postoperative course, and their correlation with immediate outcomes in patients undergoing cardiac surgery. Methodology: Patients who underwent cardiac surgery at our institute for 1 year were screened for COVID-19 with the reverse transcription-polymerase chain reaction swab test and then were posted for surgery only after corroborating negative reports, except for emergency cases. Dedicated preoperative areas and COVID-appropriate measures were taken. Data from the electronic patient records of those diagnosed with COVID-19 in the immediate postoperative period were reviewed retrospectively. Continuous normal distributed variables are presented as mean ± standard deviation, alternatively as median ± interquartile range, and categorical variables as percentages. Results: A total of 22 patients were infected in the immediate postoperative period in spite of appropriate screening and had a high mortality of 36.36% (vs. non-COVID 6.27%, P < 0.001). Days from index surgery to diagnosis were 6 (±3.75). The median stay in the intensive care unit and hospital stay was 6 (±2.75) and 10 (±3.2) days, respectively. The moderate and high-risk categories of the European System for Cardiac Operative Risk Evaluation II showed mortality of 33.3% (vs. 2.69% in non-COVID, odds ratio of 18.42) and 71.4% (vs. 11.2% in non-COVID, odds ratio of 19.65). Patients with C-reactive protein >100 mg/lit, D dimer >1000 ng/ml, and neutrophil/lymphocyte ratio >3.5 showed very high mortality. Noninvasive and invasive ventilation in 27.27% and 31.8%, respectively. Two patients acquired acute kidney injury that required hemodialysis. Conclusions: Despite requisite measures, COVID infection still remains a momentous differential to postoperative complications affecting early outcomes. Therefore, more robust preoperative protocols, better strategies for the COVID-free environment, and early clinical suspicion and workup are required to mitigate its effect on this cohort.","PeriodicalId":17503,"journal":{"name":"Journal of the Practice of Cardiovascular Sciences","volume":"9 1","pages":"41 - 45"},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Practice of Cardiovascular Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpcs.jpcs_47_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) affected care among surgical patients. Considering the underlying comorbidities, physical status, and intricate perioperative course, the cardiac surgery patient represents a vulnerable cohort. This study describes baseline characteristics, laboratory findings, diagnosis, postoperative course, and their correlation with immediate outcomes in patients undergoing cardiac surgery. Methodology: Patients who underwent cardiac surgery at our institute for 1 year were screened for COVID-19 with the reverse transcription-polymerase chain reaction swab test and then were posted for surgery only after corroborating negative reports, except for emergency cases. Dedicated preoperative areas and COVID-appropriate measures were taken. Data from the electronic patient records of those diagnosed with COVID-19 in the immediate postoperative period were reviewed retrospectively. Continuous normal distributed variables are presented as mean ± standard deviation, alternatively as median ± interquartile range, and categorical variables as percentages. Results: A total of 22 patients were infected in the immediate postoperative period in spite of appropriate screening and had a high mortality of 36.36% (vs. non-COVID 6.27%, P < 0.001). Days from index surgery to diagnosis were 6 (±3.75). The median stay in the intensive care unit and hospital stay was 6 (±2.75) and 10 (±3.2) days, respectively. The moderate and high-risk categories of the European System for Cardiac Operative Risk Evaluation II showed mortality of 33.3% (vs. 2.69% in non-COVID, odds ratio of 18.42) and 71.4% (vs. 11.2% in non-COVID, odds ratio of 19.65). Patients with C-reactive protein >100 mg/lit, D dimer >1000 ng/ml, and neutrophil/lymphocyte ratio >3.5 showed very high mortality. Noninvasive and invasive ventilation in 27.27% and 31.8%, respectively. Two patients acquired acute kidney injury that required hemodialysis. Conclusions: Despite requisite measures, COVID infection still remains a momentous differential to postoperative complications affecting early outcomes. Therefore, more robust preoperative protocols, better strategies for the COVID-free environment, and early clinical suspicion and workup are required to mitigate its effect on this cohort.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2019冠状病毒病,术后炎症状态的弹出式差异及其对心脏手术后结果的影响——单中心体验
2019冠状病毒病(COVID-19)影响手术患者的护理。考虑到潜在的合并症、身体状况和复杂的围手术期过程,心脏手术患者是一个脆弱的群体。本研究描述了心脏手术患者的基线特征、实验室结果、诊断、术后过程及其与即时预后的相关性。方法:在我院行心脏手术1年的患者,除急诊病例外,均采用逆转录聚合酶链反应拭子试验筛查COVID-19,经确证阴性报告后才行手术。采取了专门的术前区域和适合新冠病毒的措施。回顾性分析术后立即诊断为COVID-19的电子病历数据。连续正态分布变量表示为平均值±标准差,或者表示为中位数±四分位数范围,分类变量表示为百分比。结果:22例患者术后立即感染,尽管进行了适当的筛查,但死亡率高达36.36%(与未感染的患者相比为6.27%,P < 0.001)。从手术到诊断为6(±3.75)天。重症监护病房和住院时间的中位数分别为6(±2.75)天和10(±3.2)天。在欧洲心脏手术风险评估系统II中,中等和高危类别的死亡率分别为33.3%(非covid组为2.69%,优势比为18.42)和71.4%(非covid组为11.2%,优势比为19.65)。c反应蛋白>100 mg/lit, D二聚体>1000 ng/ml,中性粒细胞/淋巴细胞比值bbb3.5的患者死亡率非常高。无创通气和有创通气分别占27.27%和31.8%。2例患者获得急性肾损伤,需要血液透析。结论:尽管采取了必要的措施,COVID感染仍然是影响早期预后的术后并发症的重要差异。因此,需要更健全的术前方案,更好的无covid - 19环境策略,以及早期临床怀疑和随访,以减轻其对该队列的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of the Practice of Cardiovascular Sciences
Journal of the Practice of Cardiovascular Sciences CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
29
审稿时长
11 weeks
期刊最新文献
Venous thromboembolism and cardiopulmonary involvement in Covid 2019 patients: A retrospective observational study Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review Acute coronary syndrome in young (≤45 years) patients: An observational study Radial artery pseudoaneurysm following transradial percutaneous coronary intervention Authors should be held responsible for artificial intelligence hallucinations and mistakes in their papers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1